Protein Chip Market Statistics - 2030
Global protein chip market was valued at $652.8 million in 2020, and is projected to reach $1,367.1 million by 2030, registering a CAGR of 7.5% from 2021 to 2030. Protein chips, also known as protein microarrays are miniaturized and parallel assay systems that contain small amounts of purified proteins in a high-density format. They allow simultaneous determination of a great variety of analytes from small amounts of samples within a single experiment.
The chip consists of a support surface such as a glass slide, nitrocellulose membrane, bead, or microtiter plate to which an array of capture proteins is bound. Probe molecules, typically labeled with a fluorescent dye are added to the array. Protein microarrays are rapid, automated, economical, and highly sensitive, consuming small quantities of samples and reagents. High-throughput technology behind protein microarray is relatively easy to develop since it is based on technology developed for DNA microarrays, which have become the most widely used microarrays. This technology is used to track interactions and activities of proteins and to determine their function on a large scale.
There are two major types of protein chips: analytical protein chip and functional protein chip. Functional protein chips differ from analytical chips as functional protein arrays are composed of arrays containing full-length functional proteins or protein domains. These protein chips are used to study biochemical activities of an entire proteome in a single experiment. They are used to study numerous protein interactions, such as protein–protein, protein–DNA, protein–RNA, protein–phospholipid, and protein–small molecule interactions.
Analytical Microarrays segment holds a dominant position in 2020
Impact of COVID-19 on Protein Chips Market
The COVID-19 outbreak has impacted the global protein chip market positively. There has been a high demand for protein microarray from diagnostics laboratory due to COVID-19. In 2020, in the U.S., digital protein microarray platform for rapid multiplex quantification of cytokines from critically ill COVID-19 patients admitted to the intensive care unit (ICU) at the University of Michigan Hospital helped in a personalized strategy guided by rapid cytokine assays. In April 2020, China developed a SARS-CoV-2 proteome microarray containing 18 out of 28 predicted proteins and applied it for characterization of IgG and IgM antibody responses from 29 convalescent patients. These responses provide insights to aid development of effective diagnostic, therapeutic, and vaccination strategies. These developments are expected to foster growth of the protein chip market.
Protein Chip Market Segmentation
The protein chip market is segmented on the basis of technology, application, end user, and region. By technology, it is divided into analytical microarrays, functional protein microarrays, and reverse phase protein microarrays. The application segment includes diagnostics, proteomics, and antibody characterization. The end user segment includes hospitals & clinics, diagnostic laboratories, academic & research institutes, and pharmaceutical & biotechnological companies. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Antibody Characterization segment holds a dominant position in 2020
By technology, the analytical microarray segment held a major share in the protein chip market in 2020, and is expected to continue this trend during the forecast period.
On the basis of application, the antibody characterization segment held a major share in the protein chip market in 2020, and is expected to continue the trend during the forecast period. This is attributed to advantages that include reduction in biological sample volume, high sensitivity/specificity, and large data generation.
By end user, the academic & research institutes segment is the major contributor expected to hold largest share during the forecast period.
By End User
Academic and Research Institutes segment holds a dominant position in 2020
Region Segment Review
Region wise, North America dominated the protein chip market in 2020, owing to established protein chip laboratories and research centers in the region. However, Asia-Pacific is expected to register highest CAGR, in terms of revenue during the forecast period, owing to increase in demand for protein microarray assays along with surge in awareness. Rapid development in protein chip assays and cost-effectiveness of the test are expected to boost growth of the market in other regions.
Prominent players in the protein chip market report include Raybiotech Inc, Illumina Inc, Quotient limited, Agilent Technologies, Thermofisher Scientific, Perkin Elmer, Bio-Rad laboratories, Danher Corporation, Merck KGGA, Arrayit Corporation.
Asia-Pacific region would exhibit the highest CAGR of 8.50% during 2021-2030.
Protein Chip Market Research Study Key Benefits
- This report provides a detailed quantitative analysis of the current trends and future estimations from 2020 to 2030, which assist to identify the prevailing protein chip market opportunities.
- An in-depth market analysis includes analysis of various regions, which is anticipated to provide a detailed understanding of the current trends to enable stakeholders formulate region-specific plans.
- A comprehensive analysis of factors that drive and restrain the growth of the global is provided.
- Region wise and country wise market conditions are comprehensively analyzed in this report.
- The projections in this report are made by analyzing the current trends and future market potential from 2020 to 2030, in terms of value.
- An extensive analysis of various regions provides insights that are expected to allow companies to strategically plan their business moves.
- Key market players within the Global protein chip Market are profiled in this report and their strategies are analyzed thoroughly, which helps in understanding competitive outlook of the market.
Protein Chip Market Report Highlights
By END USER
Key Market Players
PerkinElmer Inc., Agilent Technologies Inc., QUOTIENT LIMITED, Arrayit Corporation, RayBiotech Life Inc., Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., DANAHER CORPORATION, Merck KGAA, Illumina, Inc.
According to perspectives of CXO’s of leading companies in the market, development of affordable, compact, and reliable spectrometry systems has led to extensive number of applications of this technique in various sectors. Protein chips can be used in detection of particular cancer protein for accurate cancer diagnosis and finalization of treatment therapy. Thus, increasing prevalence of cancer is anticipated to support growth of the protein chip market during the forecast period.
Biomarkers have the potential to improve early diagnosis rate of cancer. However, owing to drawback of traditional biomarkers and diagnostic methods, they are not ideal diagnostic tools for clinical practice. Thus, rise in prevalence of cancer is expected to propel demand for protein chip diagnosis, globally, impacting the protein chip market positively during the forecast period. Patients are actively opting for personalized diagnosis techniques, owing to increase in number of recommendations by doctors. As a result, there is an inclined patient preference for personalized diagnosis rather than traditional diagnosis method, as it is expected to be more accurate in disease diagnosis, which boosts the market growth. However, high cost of protein microarray (chip) is anticipated to hamper the protein chip market during the forecast period.
North America is expected to account for the highest market share, owing to established protein chip laboratories and research centers in the region, followed by Europe, Asia-Pacific, and LAMEA. Rapid development in protein chip assays and cost-effectiveness of the test are expected to boost growth of the market in other regions.